Menopause and Brain Health: Is Midlife a Window for Alzheimer’s Prevention?

This new Scientific American article looks at an important and rapidly developing area of dementia research: whether the menopause transition represents a period when women may be able to influence their future risk of Alzheimer’s disease.

What you’ll learn

Women account for close to two-thirds of people with Alzheimer’s disease, and researchers are increasingly investigating whether this difference is about more than women simply living longer. Hormonal and neurological changes around menopause may be part of the picture.

Two new studies highlighted by Scientific American provide particularly interesting findings.

One followed more than 180,000 postmenopausal women in the UK for around 13 years. Women who had used hormone replacement therapy (HRT) were associated with:

• 10% lower risk of dementia overall
• 16% lower risk of Alzheimer’s disease
• 26% lower dementia risk among women who had experienced surgical menopause

Women who began HRT between approximately 46 and 56 years of age also appeared to have lower dementia risk than women who began treatment later. Importantly, this was an observational study, so it cannot prove that HRT itself caused the reduction in risk.

A second study found that earlier menopause was associated with greater cognitive decline later in life and an earlier diagnosis of Alzheimer’s disease. Researchers also detected changes in the brain decades later, suggesting that the timing of menopause may have lasting neurological consequences.

Why the “window of opportunity” matters

Perhaps the most important message isn’t simply about HRT.

It is the growing recognition that Alzheimer’s prevention may need to begin decades before dementia develops.

A 2026 scientific review by neuroscientist Lisa Mosconi describes women’s midlife as potentially being the “front line” of Alzheimer’s prevention, arguing that menopause-related hormonal changes, early menopause and surgical removal of the ovaries deserve much greater attention when assessing a woman’s future dementia risk.

HEAL takeaway

Midlife may be one of the most important times for women to start thinking about their future brain health.

Menopause doesn’t mean a woman will develop Alzheimer’s disease, and HRT is not currently an established dementia-prevention treatment. But emerging research suggests that the hormonal changes occurring during menopause—and particularly early or surgical menopause—may help identify women who could benefit from earlier attention to their long-term brain health.

That makes the menopause transition an important opportunity to look at the things we can influence: physical activity, cardiovascular and metabolic health, nutrition, sleep, smoking, alcohol, social connection, cognitive engagement and management of conditions such as high blood pressure, cholesterol and diabetes.

Read the Scientific American article

A quick note from HEAL: This summary is for general education and does not replace personalised medical advice. Decisions about menopause hormone therapy should be discussed with a qualified health professional.